Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.8M Sell
201,240
-19,503
-9% -$4.33M 0.67% 30
2025
Q4
$50.4M Sell
220,743
-16,266
-7% -$3.71M 0.77% 26
2025
Q3
$54.9M Sell
237,009
-8,422
-3% -$1.72M 0.83% 25
2025
Q2
$45.6M Sell
245,431
-4,748
-2% -$882K 0.74% 25
2025
Q1
$52.4M Sell
250,179
-18,326
-7% -$3.56M 0.93% 19
2024
Q4
$47M Sell
268,505
-101
-0% -$18.6K 0.79% 24
2024
Q3
$52.5M Buy
268,606
+3,676
+1% +$686K 0.93% 21
2024
Q2
$45.4M Buy
264,930
+5,003
+2% +$829K 0.82% 24
2024
Q1
$47M Sell
259,927
-59,413
-19% -$10.2M 0.86% 21
2023
Q4
$49.5M Buy
319,340
+15,642
+5% +$2.28M 0.97% 17
2023
Q3
$42.9M Sell
303,698
-11,274
-4% -$1.66M 0.95% 16
2023
Q2
$42.4M Sell
314,972
-16,086
-5% -$2.36M 0.86% 21
2023
Q1
$52.8M Sell
331,058
-42,893
-11% -$6.56M 1.1% 10
2022
Q4
$60.4M Sell
373,951
-6,396
-2% -$981K 1.12% 11
2022
Q3
$51M Sell
380,347
-28,913
-7% -$4.15M 1.03% 12
2022
Q2
$62.7M Sell
409,260
-4,257
-1% -$650K 1.2% 11
2022
Q1
$67M Sell
413,517
-3,040
-0.7% -$442K 1.1% 10
2021
Q4
$56.4M Sell
416,557
-262,156
-39% -$31M 0.87% 17
2021
Q3
$73.2M Buy
+678,713
New +$77.6M 1.26% 9
2021
Q1
$123M Buy
1,135,803
+14,544
+1% +$1.56M 2.24% 4
2020
Q4
$120M Buy
1,121,259
+809,846
+260% +$77.8M 2.29% 4
2020
Q3
$27.3M Buy
311,413
+40,559
+15% +$3.82M 0.6% 34
2020
Q2
$26.6M Buy
270,854
+59,786
+28% +$5.26M 0.63% 32
2020
Q1
$16.1M Buy
211,068
+49,138
+30% +$4.19M 0.46% 49
2019
Q4
$14.3M Buy
161,930
+246
+0.2% +$20.4K 0.32% 71
2019
Q3
$12.2M Buy
161,684
+16,280
+11% +$1.12M 0.29% 79
2019
Q2
$10.6M Buy
145,404
+13,402
+10% +$1.05M 0.25% 95
2019
Q1
$10.6M Sell
132,002
-83,454
-39% -$6.83M 0.25% 91
2018
Q4
$19.9M Buy
215,456
+17,226
+9% +$1.51M 0.57% 38
2018
Q3
$18.7M Buy
198,230
+17,398
+10% +$1.65M 0.47% 45
2018
Q2
$16.8M Buy
180,832
+55,672
+44% +$5.44M 0.45% 50
2018
Q1
$11.8M Sell
125,160
-3,992
-3% -$439K 0.34% 72
2017
Q4
$12.5M Sell
129,152
-6,781
-5% -$639K 0.34% 71
2017
Q3
$12.1M Buy
+135,933
New +$10.3M 0.35% 72
2017
Q2
Sell
-151,096
Closed -$9.85M 883
2017
Q1
$9.85M Buy
151,096
+3,479
+2% +$219K 0.31% 79
2016
Q4
$9.24M Buy
147,617
+730
+0.5% +$44.6K 0.3% 82
2016
Q3
$9.26M Buy
146,887
+13,264
+10% +$859K 0.31% 81
2016
Q2
$8.27M Sell
133,623
-8,265
-6% -$504K 0.29% 87
2016
Q1
$8.1M Buy
141,888
+10,833
+8% +$604K 0.29% 88
2015
Q4
$7.76M Sell
131,055
-42,216
-24% -$2.43M 0.28% 83
2015
Q3
$9.43M Buy
173,271
+7,544
+5% +$491K 0.35% 67
2015
Q2
$11.1M Buy
165,727
+14,081
+9% +$919K 0.38% 65
2015
Q1
$8.88M Sell
151,646
-16,566
-10% -$1M 0.3% 81
2014
Q4
$11M Sell
168,212
-43,611
-21% -$2.75M 0.38% 59
2014
Q3
$12.2M Buy
211,823
+16,674
+9% +$926K 0.41% 52
2014
Q2
$11M Sell
195,149
-9,871
-5% -$518K 0.35% 61
2014
Q1
$10.5M Sell
205,020
-19,050
-9% -$963K 0.35% 58
2013
Q4
$11.8M Buy
224,070
+15,866
+8% +$780K 0.4% 47
2013
Q3
$9.31M Sell
208,204
-17,333
-8% -$768K 0.34% 63
2013
Q2
$9.32M Buy
+225,537
New +$9.86M 0.35% 63

Other funds holding ABBV

BOK Financial's ABBV Position: Q1 2026 in Review

BOK Financial reduced its AbbVie (ABBV) stake by 8.8% in Q1 2026, selling an estimated $4.33M and leaving 201,240 shares worth $43.8M. The position accounts for 0.67% of the portfolio, ranked #30.

BOK Financial first reported a position in ABBV in Q2 2013 and has held it in 50 quarters since. The position peaked at $123M in Q1 2021. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • BOK Financial held 201,240 shares of AbbVie worth $43.8M as of Q1 2026.
  • BOK Financial sold 19,503 AbbVie shares in Q1 2026, an estimated $4.33M.
  • AbbVie made up 0.67% of BOK Financial's portfolio in Q1 2026, its #30 holding.
  • BOK Financial first reported a position in AbbVie in Q2 2013 and has held it in 50 quarters since.
  • BOK Financial's AbbVie position peaked at $123M in Q1 2021.
  • 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on BOK Financial's 13F filing for Q1 2026, filed 8 May 2026.